Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies (LIBERTY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03096834
Recruitment Status : Completed
First Posted : March 30, 2017
Last Update Posted : December 6, 2021
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 18, 2018
Actual Study Completion Date : January 28, 2021
Certification/Extension First Submitted : September 16, 2019
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):